• Bringing 'Precision' to Life!
  • 13687 Neil Armstrong AveHerndon VA 20171 USA
  • Call Us+1 5402390465
  • Email Usinfo@jeevadx.com


Bringing 'Precision' to Life!

Jeeva Informatics Solutions (Jeeva) is a premier healthcare and life sciences informatics company with the vision to democratize precision medicine with solutions in OMICS, translational research, and digital health technologies.

Jeeva is unique among small businesses in its dedicated and specialized focus on precision medicine for healthcare and life science clients. Led by accomplished senior scientists, Jeeva provides consulting around BioHealth IT and Data strategy as well as full execution support of end to end solutions for federal, academic and industry customers in healthcare and life sciences. Jeeva was founded to solve the data deluge problems facing healthcare and life science stakeholders as the cost of producing data is going down exponentially shifting the focus towards analyzing and interpreting data. applying industry best practices.


Jeeva’s core strengths lie in strategic research and development programs from concept to full implementation including laboratory data generation and Bioinformatics analysis of BigData. This includes next-generation sequencing (NGS) and other high-throughput molecular biology and biochemical platforms.

Founded on successful delivery of multidisciplinary projects at the National Institutes of Health (NIH) and Food and Drug Administration (FDA), as well as projects for various non-profit institutions and companies, Jeeva currently provides bioinformatics and data analysis services to multiple biomedical research institutions including Morehouse School of Medicine, Catholic Health Initiatives and the state of Maryland.

Jeeva received 'Bioscience Company of the Year 2014' Award from the Montgomery County Department of Economic Development, Maryland, USA.

Harsha K. Rajasimha, MS, PhD


Dr. Harsha Rajasimha work over the last 17 years has focused on data-driven, value-based, precision medicine R&D and commercial programs for cancer and other diseases. He serves on the commercial relevance advisory board of BioHealth Innovation, a non-profit organization attracting investments to Maryland. Earlier, he led the global strategy and business development for Strand Life Sciences, a CAP/CLIA precision medicine diagnostics company and Bioinformatics powerhouse.

Dr. Rajasimha has led the development of some of the largest genomics projects including PathogenPortal, Pathosystems resource integration center, Cancer Biomedical Informatics Grid (caBIG), LIMS implementation at the FDA Office of Regulatory Affairs, architected Genome Explorer® a web-based platform for next-generation sequencing (NGS) data analysis for Genome International Corporation and Cyberinfrastructure development for National Eye Institute’s genomics program. His contributions to the NGS program were recognized by NEI director’s innovation award in 2012. More recently, in collaboration with rare genomics institute, he received the Sanofi Genzyme patient advocacy leadership award 2016 and a NTT DATA Healthcare and Life Sciences Silver award for outstanding achievement and impact on business unit’s fiscal year initiatives 2017.

Dr. Rajasimha has authored over 15 peer-reviewed articles, book chapters, inventor on patents and is often invited speaker at international conferences and executive consultant/advisor to a number of biotech startups. He has contributed to global data standards initiatives such as GA4GH, BioPAX, DELSAGlobal, and the personalized medicine coalition. He earned baccalaureate degree in computer engineering from Bangalore University, Masters in Computer Science and Doctorate in genetics, bioinformatics and computational biology from Virginia Tech.

Industry Expertise

  • Healthcare and Life Sciences
  • Bigdata in OMICS and Precision Medicine
  • Molecular Diagnostics
  • Computational Drug Discovery & Development
  • Rare Diseases Translational Research | Patient Advocacy
  • Government: NEI | NCI | NIAID | NIH | FDA

Domain Expertise

  • Biopharma R&D and commercial use cases
  • Genetics | Next-Generation Sequencing data analysis and interpretation
  • Systems Biology and Systems Medicine modeling and simulation
  • Clinical Decision Support
  • Oncology | Rare Diseases | Eye | Other
  • Data Standards and Exchange formats
  • Laboratory Information Management Systems
  • OMICs Environment and Health
  • Compliance: CAP/CLIA | HIPAA 21 | CFR Part11 | 508

Technology Expertise

  • Molecular Biology databases and tools
  • Open source and commercial software for data analysis | workflows | visualization.
  • Web- and Cloud and On-Premise Infrastructure
  • Machine learning | Cognitive computing

Our Advisory Board

Eric J. Klos

CEO and Founder, HEALTHeWeather
Strategic Advisor

Michael R. Fannon

President, BioIT Solutions
Strategic Advisor

Dr.Ancha Baranova

Professor, School of Systems Biology

Sanjay Joshi

Chief of Technology

Dr. Kathleen Kennedy Norris

BCCC Life Sciences Institute (LSI) Director